Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C263/00—Preparation of derivatives of isocyanic acid
  • C07C263/10—Preparation of derivatives of isocyanic acid by reaction of amines with carbonyl halides, e.g. with phosgene
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
  • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
  • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
  • A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K49/00—Preparations for testing in vivo
  • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
  • A61K51/04—Organic compounds
  • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
  • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
  • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
  • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
  • C07F15/0073—Rhodium compounds
  • C07F15/008—Rhodium compounds without a metal-carbon linkage
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2123/00—Preparations for testing in vivo

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Epidemiology (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Immunology (AREA)
• Engineering & Computer Science (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Pharmacology & Pharmacy (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Biomedical Technology (AREA)
• Physics & Mathematics (AREA)
• Optics & Photonics (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
• Medicinal Preparation (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Inorganic Compounds Of Heavy Metals (AREA)
• Compositions Of Macromolecular Compounds (AREA)
• Solid-Sorbent Or Filter-Aiding Compositions (AREA)
• Peptides Or Proteins (AREA)

Applications Claiming Priority (1)

Publications (2)

Family

ID=22064774

Family Applications (1)

Country Status (19)

Families Citing this family (107)

Family Cites Families (10)

• 1987
  • 1987-06-24 US US07/065,739 patent/US4994560A/en not_active Expired - Fee Related
• 1988
  • 1988-06-15 CA CA000569508A patent/CA1341349C/en not_active Expired - Fee Related
  • 1988-06-17 NZ NZ225070A patent/NZ225070A/xx unknown
  • 1988-06-20 DE DE3855564T patent/DE3855564T2/de not_active Expired - Fee Related
  • 1988-06-20 EP EP88109799A patent/EP0296522B1/de not_active Expired - Lifetime
  • 1988-06-20 AT AT88109799T patent/ATE143364T1/de not_active IP Right Cessation
  • 1988-06-20 ES ES88109799T patent/ES2091746T3/es not_active Expired - Lifetime
  • 1988-06-22 DK DK343288A patent/DK343288A/da not_active Application Discontinuation
  • 1988-06-22 IL IL8683588A patent/IL86835A/en not_active IP Right Cessation
  • 1988-06-23 HU HU883188A patent/HU201333B/hu not_active IP Right Cessation
  • 1988-06-23 FI FI883046A patent/FI101378B1/fi not_active IP Right Cessation
  • 1988-06-23 NO NO882784A patent/NO178928C/no not_active IP Right Cessation
  • 1988-06-23 PT PT87802A patent/PT87802B/pt not_active IP Right Cessation
  • 1988-06-24 KR KR1019880007673A patent/KR970011005B1/ko not_active Expired - Fee Related
  • 1988-06-24 CN CN88104543A patent/CN1022839C/zh not_active Expired - Fee Related
  • 1988-06-24 ZA ZA884545A patent/ZA884545B/xx unknown
  • 1988-06-24 JP JP63155058A patent/JP2728437B2/ja not_active Expired - Fee Related
• 1990
  • 1990-11-28 US US07/619,153 patent/US5284644A/en not_active Expired - Lifetime
• 1996
  • 1996-11-06 GR GR960402911T patent/GR3021537T3/el unknown
• 1998
  • 1998-06-13 HK HK98105268A patent/HK1006168A1/en not_active IP Right Cessation

Also Published As

Similar Documents

Legal Events